Myeloperoxidase deficiency (MOD) is a rare inherited disorder characterized by a deficiency of myeloperoxidase, an enzyme involved in the formation of reactive oxygen species in neutrophils. This enzyme plays a key role in the immune system, providing protection against pathogens through oxidative reactions. In myeloperoxidase deficiency, neutrophil function is impaired, leading to a reduced ability to fight infections, especially bacterial ones. Clinical manifestations can range from a mild predisposition to infections to severe forms requiring intensive treatment and monitoring. Importantly, this condition can remain undetected for a long time, making diagnosis and timely intervention difficult.
History of the disease and interesting historical facts
Myeloperoxidase deficiency was first described in the scientific literature in the 1960s. Since then, data on its genetic nature and clinical manifestations have accumulated. In the 1970s, researchers began to associate this deficiency with increased susceptibility to infections, which became the subject of numerous studies. One of the interesting facts is that the pathology was found in various ethnic groups, which indicates its wide distribution and the need for careful study. In addition, this disease has become a subject of interest for geneticists studying the mechanism of transmission of hereditary diseases.
Epidemiology
Myeloperoxidase deficiency is a rare disease: its incidence varies depending on the population and ethnic group. Current estimates suggest an incidence of approximately 0.5-1 case per 10,000 people in the population. However, in some cases, particularly in certain ethnic groups, the incidence may be significantly higher. For example, in African-American populations, the incidence may be as high as 5-10%. About 20% of patients with confirmed myeloperoxidase deficiency have recurrent infections, highlighting the need for screening programs and preventive measures.
Genetic predisposition to this disease
Myeloperoxidase deficiency is an inherited disorder that is transmitted in an autosomal recessive manner. The major gene involved in the disorder is MPO (myeloperoxidase), which is located on chromosome 17. More than 30 different mutations are known to be associated with the condition, most of which result in partial or complete absence of functional enzyme. Mutations can range from point changes to deletions, which influence the severity of the clinical picture and the degree of endogenous susceptibility to infections. Genetic testing can aid in diagnosis and identification of carriers among potential parents.
Risk factors for the development of this disease
There are several factors that can contribute to myeloperoxidase deficiency:
- Hereditary predisposition: Having affected relatives may increase the risk.
- Ethnicity: Certain groups, such as Africans and Jews, have a higher risk.
- Age: Although the disease can manifest at any age, it is often diagnosed in childhood.
- Environmental influences: Some chemicals can impair the immune response.
- Infectious diseases: The presence of chronic infections may aggravate the condition of patients with enzyme deficiency.
Diagnosis of this disease
Diagnosis of myeloperoxidase deficiency involves a number of steps:
- Main symptoms: recurrent bacterial infections, especially those caused by encapsulated organisms.
- Laboratory tests: Blood test for myeloperoxidase level and neutrophil functional testing.
- Radiological examinations: may be needed to assess the condition of organs in the presence of infections.
- Other types of diagnostics: genetic testing to confirm mutations.
- Differential diagnosis: Other immunodeficiencies and blood disorders such as Kostmann syndrome and other forms of hereditary neutropenia must be excluded.
Treatment
Treatment of myeloperoxidase deficiency should be comprehensive and individualized:
- General treatment: includes high vigilance for signs of infection and timely use of antibiotics.
- Pharmacological treatment: may include colony-stimulating factors to stimulate neutrophil production.
- Surgical treatment: In rare cases, removal of chronic infectious foci may be required.
- Other types of treatment: Immunostimulating therapy, vaccination and supportive therapy to enhance the immune response.
List of medications used to treat this disease
There are several groups of medications that can be used to treat myeloperoxidase deficiency:
- Antibiotics: ampicillin, cephalexin for the prevention and treatment of infections.
- Granulocyte colony-stimulating factors (G-CSF): filgrastim (Granoxy) to stimulate neutrophil production.
- Immunomodulators: various drugs that increase the overall immune response.
- Vaccines for the prevention of infections.
Disease monitoring
Monitoring the condition of patients with myeloperoxidase deficiency is important for prevention and timely intervention:
- Control stages: Regular clinical examination and blood tests to assess neutrophil levels and immune system status.
- Forecast: With adequate management, symptoms may be minimal, but some patients may experience chronic infections.
- Complications: A high susceptibility to bacterial infections may result in the need for surgery or frequent hospitalizations.
Age-related features of the disease
Myeloperoxidase deficiency can occur at any age, but there are some specific features:
- In neonates and infants: high susceptibility to infections, careful monitoring and early intervention required.
- In children: recurring bacterial infections occur, often resulting in the need for antibiotic therapy.
- In adults: Some patients may adapt and have less severe symptoms, but infectious risks remain.
Questions and Answers
- What is myeloperoxidase deficiency? It is a rare inherited disorder associated with a deficiency of the enzyme myeloperoxidase, resulting in impaired neutrophil function and an increased risk of infections.
- What are the symptoms of myeloperoxidase deficiency? The main symptoms include recurrent bacterial infections, mainly caused by capsule-dependent organisms, and possible inflammatory reactions.
- How is this disease diagnosed? Diagnosis is based on clinical presentation, laboratory tests for myeloperoxidase levels, and genetic testing.
- How is myeloperoxidase deficiency treated? Treatment includes antibiotics to prevent infections, colony-stimulating factors, and, if necessary, surgery.
- What is the prognosis for patients with myeloperoxidase deficiency? With ongoing monitoring and appropriate treatment, many patients can lead a virtually normal life, but there is a risk of chronic infections.
